However, under certain conditions, Deptor may act as an oncogene involved in the feedback inhibition of PI3K by S6K1, thereby activating mTORC2/AKT, and contributing to AKT activation in multiple myeloma and triple-negative breast cancer, which is associated with drug resistance and tumor metastasis [24, 25]. Here, AKT1 is linked to plasma cell myeloma.